MolMed Overview

  • Founded
  • 1996
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 223
Employees
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 7
  • Investments
  • 1

MolMed General Information

Description

Molmed SpA is an Italy based medical biotechnology company. It is engaged in research, development and clinical validation of innovative therapies to treat cancer. The company's therapies include TK for blood cancers and NGR-hTNF for solid tumors. Its pipeline includes antitumor therapeutics in clinical and preclinical development.

Contact Information

Website
www.molmed.com
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Acquirer
AGC Biologics
Primary Office
  • Via Olgettina 58
  • 20132 Milan
  • Italy
+39 0000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

MolMed Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore MolMed‘s full profile, request access.

Request a free trial

MolMed Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Molmed SpA is an Italy based medical biotechnology company. It is engaged in research, development and clinical validati
Biotechnology
Milan, Italy
223 As of 2020
00000
0000 0000-00-00
000000&0 00000

00000

gna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea
0000000000000
Cambridge, MA
000 As of 0000
00000
000000&0

000000 0

nsequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat null
0000 000000000
Amsterdam, Netherlands
000 As of 0000
00000
0000 0000-00-00
000000&0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

MolMed Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Agios Formerly VC-backed Cambridge, MA 000 00000 000000&0
000000 000000 Formerly VC-backed Amsterdam, Netherlands 000 00000 000000&0 00000
You’re viewing 2 of 2 competitors. Get the full list »

MolMed Patents

MolMed Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
DE-69916829-D1 Genetically modified fibroblasts and their use Expired - Fee Related 08-May-1998 0000000000
EP-1084232-B1 Genetically-modified fibroblasts and the use thereof Expired - Lifetime 08-May-1998 0000000000
EP-1084232-A1 Genetically-modified fibroblasts and the use thereof Granted 08-May-1998 0000000000
AU-4037299-A Genetically-modified fibroblasts and the use thereof Abandoned 08-May-1998 0000000000
CA-2331826-A1 Genetically-modified fibroblasts and the use thereof Abandoned 08-May-1998 C12N5/0658
To view MolMed’s complete patent history, request access »

MolMed Executive Team (5)

Name Title Board Seat Contact Info
Riccardo Palmisano MD Chief Executive Officer
Claudio Bordignon MD Founder & Chairman
You’re viewing 2 of 5 executive team members. Get the full list »

MolMed Board Members (13)

Name Representing Role Since
0000000 000000000 00 MolMed Founder & Chairman 000 0000
You’re viewing 1 of 13 board members. Get the full list »

MolMed Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MolMed Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore MolMed‘s full profile, request access.

Request a free trial

MolMed Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 01-Jan-2002 0000000000 Biotechnology
To view MolMed’s complete acquisitions history, request access »